Review of Global Clinical Trials in Diabetic Foot Ulcers, First Half 2021 Research Report – ResearchAndMarkets.com


DUBLIN – (COMMERCIAL THREAD) – Clinical trials “Diabetic Foot Ulcers – Global Clinical Trials Review, H1, 2021” have been added to ResearchAndMarkets.com offer.

This report presents key data from clinical trials in diabetic foot ulcers. The report includes an overview of the numbers of trials and their average number of registrations in major countries conducted around the world.

The report offers disease clinical trial coverage by region, country (G7 and E7), phase, trial status, endpoint status, and sponsor type. The report also provides important drugs for ongoing trials (based on number of ongoing trials).

The report improves decision-making abilities and helps create effective counter-strategies to gain competitive advantage.

Scope

  • Report Provides Overview of Global Clinical Trials Landscape
  • Report provides high level clinical trial data by region, country (G7 & E7), trial status, trial phase, sponsor type and endpoint status
  • The report reviews the main companies involved and identifies all trials (trial title, phase and status) related to the company
  • The report provides all unfinished trials (completed, suspended and withdrawn) with the reason for the failure
  • The report presents enrollment trends over the past five years
  • The report provides the latest news from the past three months

Reasons to buy

  • Help formulate key business investment strategies
  • Helps identify important locations for conducting clinical trials, saving time and money
  • Provides high-level analysis of the global clinical trials market which helps in identifying major business opportunities
  • Supports understanding of trial count and enrollment trends by country in the global therapeutics market
  • Helps interpret clinical trial success rates by providing a comparative scenario of completed and unfinished (completed, suspended or withdrawn) trials
  • Facilitates the evaluation of clinical trials of the indication at global, regional and national levels

Main topics covered:

  • Orientation report
  • Coverage of clinical trial reports
  • Clinical trials by region
  • Clinical trials and average enrollment by country
  • Top five countries contributing to clinical trials in Asia-Pacific
  • Top five countries contributing to clinical trials in Europe
  • Main countries contributing to clinical trials in North America
  • Top five countries contributing to clinical trials in the Middle East and Africa
  • Top five countries contributing to clinical trials in Central and South America
  • Clinical trials from G7 countries: proportion of diabetic foot ulcers to metabolic disorders Clinical trials
  • Clinical trials by phase in G7 countries
  • Clinical trials in G7 countries by trial status
  • Clinical trials by country E7: Proportion of diabetic foot ulcers in relation to metabolic disorders Clinical trials
  • Clinical trials by phase in E7 countries
  • Clinical trials in E7 countries by trial status
  • Clinical trials by phase
  • Ongoing trials by phase
  • Clinical trials by trial status
  • Clinical trials by endpoint status
  • Subjects recruited over a period of time
  • Clinical trials by type of sponsor
  • Leading Sponsors
  • Main companies participating in therapeutic clinical trials on diabetic foot ulcers
  • Important drugs
  • Snapshots of clinical trial profiles
  • appendix

Companies mentioned

  • Smith & Nephew Plc
  • Anterogen Co Ltd
  • Innocoll Holdings SA
  • Intégra LifeSciences Holdings Corp
  • CytoTools AG
  • Pfizer Inc
  • ArcticZymes Technologies ASA
  • Dipexium Pharmaceuticals Inc (inactive)
  • F. Hoffmann-La Roche Ltée
  • GlaxoSmithKline Plc

For more information on this clinical trial report, visit https://www.researchandmarkets.com/r/xzzsdo


Comments are closed.